Nebraska Attorney General Joins Lawsuit Targeting Marijuana

State Intervention in Cannabis Litigation

Nebraska's Attorney General has formally intervened in pending litigation challenging the state's marijuana regulatory framework. Mike Hilgers filed a motion to join the case as a party on May 29, according to court records. The lawsuit, originally brought by opponents of the state's medical cannabis program, contests the implementation timeline and regulatory structure established after voters approved Initiative 437 and Initiative 438 in November 2024.

The dual ballot measures passed with 70.7% and 66.9% support respectively. Initiative 437 legalized medical marijuana possession and use for qualified patients. Initiative 438 directed the state Department of Health and Human Services to establish a regulatory framework by July 1, 2025.

Legal Challenge to Regulatory Timeline

The lawsuit centers on whether state agencies exceeded their statutory authority in setting implementation deadlines. Plaintiffs argue the Department of Health and Human Services moved too quickly to draft regulations without adequate public input. They cite Nebraska Administrative Procedure Act requirements for rulemaking transparency.

Hilgers' office hasn't issued a public statement detailing the state's legal position. The Attorney General's intervention typically signals the state will defend its regulatory process or seek to clarify ambiguous statutory language.

Implementation Status and Operator Impact

Nebraska's medical cannabis program remains in pre-operational status nine months after voter approval. No cultivation or dispensary licenses have been issued. The Department of Health and Human Services published draft regulations in March 2025 but withdrew them for revision after receiving over 800 public comments.

Prospective operators face mounting uncertainty. Real estate leases, equipment purchases, and staffing plans are on hold pending regulatory clarity. One Omaha-based applicant group told local media in April that legal delays had already cost the consortium $2.3 million in pre-operational expenses.

Political Context and Opposition Strategy

The lawsuit represents the latest attempt by cannabis opponents to slow or halt implementation despite clear voter support. Former State Senator John Kuehn, a vocal critic of medical marijuana, is listed as lead plaintiff. Kuehn has said the initiatives violate federal law and shouldn't be implemented regardless of voter intent.

Nebraska remains one of three states where medical cannabis is legal by ballot measure but not yet operational. South Dakota faced similar litigation after voters approved medical marijuana in 2020. That program didn't launch until 2022 after courts resolved constitutional challenges.

Federal Scheduling Context

The Nebraska litigation unfolds as federal marijuana policy undergoes potential reclassification. The DEA published a Notice of Proposed Rulemaking in May 2024 proposing to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. That rulemaking remains pending. A final rule isn't expected until late 2026 at the earliest.

Nebraska's medical program, as drafted, references federal scheduling. If cannabis moves to Schedule III, state regulations may require amendment to align possession limits and qualifying conditions with the new federal classification.

Procedural Timeline and Next Steps

The court hasn't yet ruled on Hilgers' motion to intervene. A hearing is scheduled for June 18, 2026, in Lancaster County District Court. If the motion is granted, the Attorney General's office will file a formal answer to the complaint within 30 days.

Separately, the Department of Health and Human Services has indicated it'll publish revised draft regulations by June 30, regardless of litigation status. That timeline would still allow the state to meet the July 1, 2025 statutory deadline if the court doesn't issue an injunction.

Implications for Regional Policy

Nebraska's legal impasse has drawn attention from neighboring states with operational medical programs. Iowa and Missouri regulators have noted that delays in Nebraska could push patient demand across state lines, complicating reciprocity enforcement.

For full background on this story, see the CannIntel topic hub on Nebraska Marijuana Legalization.

The litigation also tests a broader question: whether state courts will defer to voter-approved ballot measures or allow procedural challenges to indefinitely delay implementation. That precedent could influence cannabis policy fights in other initiative states.

Two signals matter now. The June 18 hearing. The Department's revised draft rules by month-end.